Previous Close | 10.08 |
Open | 10.00 |
Bid | 10.07 x 36200 |
Ask | 10.08 x 317000 |
Day's Range | 10.00 - 10.09 |
52 Week Range | 9.15 - 13.14 |
Volume | |
Avg. Volume | 110,443 |
Market Cap | 18.127B |
Beta (5Y Monthly) | 0.22 |
PE Ratio (TTM) | 50.45 |
EPS (TTM) | 0.20 |
Earnings Date | Feb 03, 2025 - Feb 07, 2025 |
Forward Dividend & Yield | 0.46 (4.57%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 12.40 |
The solution offers clinicians detailed patient reports, which feature important cardio acoustic biomarkers.
Astellas Pharma U.S., Inc. (President: Mike Petroutsas, "Astellas") today announced that it has entered into an agreement with Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, to pilot DIGITIVA™, a non-invasive digital health solution for the management of heart failure patients. In the next few weeks, eligible patients receiving care with DOHC will begin using DIGITIVA as a new method for managing their heart health while working in partnership with their healthcare team.